欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3841/002
药品名称Meropenem Bradex 1 g, powder for solution for injection/infusion
活性成分
    • Meropenem trihydrate 1.0 g
剂型Powder for solution for injection/infusion
上市许可持有人BRADEX S.A., Pharmaceutical Products 27 Askipiou str, Krioneri Greece
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Denmark (DK)
      Meropenem "Bradex"
    • Belgium (BE)
      Meropenem BRADEX
    • Luxembourg (LU)
      Meropenem Bradex, 1g, Poudre pour solution pour injection/perfusion
    • France (FR)
    • Sweden (SE)
    • Norway (NO)
      Meropenem Bradex
    • Hungary (HU)
      Meropenem Bradex
    • Czechia (CZ)
      Meropenem BRADEX 1g, prášek pro injekční/infuzní roztok
许可日期2018/02/21
最近更新日期2024/11/21
药物ATC编码
    • J01DH02 meropenem
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase